25 XP   0   0   10

Adial Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Adial Pharmaceuticals Inc together

PenkeI guess you are interested in Adial Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Adial Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Adial Pharmaceuticals Inc

I send you an email if I find something interesting about Adial Pharmaceuticals Inc.

Quick analysis of Adial Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Adial Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.45
Expected worth in 1 year
$4.57
How sure are you?
32.3%

+ What do you gain per year?

Total Gains per Share
$2.12
Return On Investment
109.8%

For what price can you sell your share?

Current Price per Share
$1.93
Expected price per share
$0.765 - $4.46
How sure are you?
50%

1. Valuation of Adial Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$1.93

Intrinsic Value Per Share

$-106,260.05 - $-121,820.13

Total Value Per Share

$-106,257.60 - $-121,817.68

2. Growth of Adial Pharmaceuticals Inc (5 min.)




Is Adial Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$4m$4.5m-$1.2m-39.3%

How much money is Adial Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$739.1k-$3.1m$2.4m328.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Adial Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#777 / 1016

Most Revenue
#929 / 1016

Most Profit
#222 / 1016

Most Efficient
#383 / 1016

What can you expect buying and holding a share of Adial Pharmaceuticals Inc? (5 min.)

Welcome investor! Adial Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Adial Pharmaceuticals Inc.

What can you expect buying and holding a share of Adial Pharmaceuticals Inc?

First you should know what it really means to hold a share of Adial Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Adial Pharmaceuticals Inc is $1.93. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Adial Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Adial Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.45. Based on the TTM, the Book Value Change Per Share is $0.53 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Adial Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.15-59.8%-0.44-23.0%-0.72-37.2%-1.46-75.6%-1.22-63.4%
Usd Book Value Change Per Share1.0554.3%0.5327.4%-1.39-72.2%-0.24-12.5%0.084.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.0554.3%0.5327.4%-1.39-72.2%-0.24-12.5%0.084.1%
Usd Price Per Share1.33-1.44-0.56-1.72-1.42-
Price to Earnings Ratio-0.29--0.35-0.01--0.24--0.22-
Price-to-Total Gains Ratio1.27--1.09--0.38--0.80--1.42-
Price to Book Ratio0.54-0.87-0.23-0.56-0.45-
Price-to-Total Gains Ratio1.27--1.09--0.38--0.80--1.42-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.93
Number of shares518
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.53-0.24
Usd Total Gains Per Share0.53-0.24
Gains per Quarter (518 shares)274.42-125.34
Gains per Year (518 shares)1,097.68-501.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10109810880-501-511
20219521860-1003-1012
30329332840-1504-1513
40439143820-2005-2014
50548854800-2507-2515
60658665780-3008-3016
70768476760-3509-3517
80878187740-4011-4018
90987998720-4512-4519
10010977109700-5013-5020

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.02.00.033.3%3.08.00.027.3%3.016.00.015.8%3.028.00.09.7%3.028.00.09.7%
Book Value Change Per Share2.01.00.066.7%4.07.00.036.4%6.013.00.031.6%10.019.02.032.3%10.019.02.032.3%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%0.00.031.00.0%0.00.031.00.0%
Total Gains per Share2.01.00.066.7%4.07.00.036.4%6.013.00.031.6%10.019.02.032.3%10.019.02.032.3%

Fundamentals of Adial Pharmaceuticals Inc

About Adial Pharmaceuticals Inc

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Fundamental data was last updated by Penke on 2024-04-10 23:37:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Adial Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Adial Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Adial Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY--279.3%+279.3%
5Y--438.4%+438.4%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Adial Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • -40.5% Return on Assets means that Adial Pharmaceuticals Inc generated $-0.41 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Adial Pharmaceuticals Inc:

  • The MRQ is -40.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -20.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-40.5%TTM-20.0%-20.5%
TTM-20.0%YOY-49.7%+29.6%
TTM-20.0%5Y-38.7%+18.7%
5Y-38.7%10Y-150.1%+111.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.5%-13.5%-27.0%
TTM-20.0%-12.9%-7.1%
YOY-49.7%-11.8%-37.9%
5Y-38.7%-14.1%-24.6%
10Y-150.1%-16.0%-134.1%
1.1.3. Return on Equity

Shows how efficient Adial Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • -47.0% Return on Equity means Adial Pharmaceuticals Inc generated $-0.47 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Adial Pharmaceuticals Inc:

  • The MRQ is -47.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -24.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-47.0%TTM-24.5%-22.5%
TTM-24.5%YOY-98.2%+73.7%
TTM-24.5%5Y-61.1%+36.7%
5Y-61.1%10Y-66.3%+5.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-47.0%-16.9%-30.1%
TTM-24.5%-16.1%-8.4%
YOY-98.2%-15.1%-83.1%
5Y-61.1%-19.9%-41.2%
10Y-66.3%-20.9%-45.4%

1.2. Operating Efficiency of Adial Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Adial Pharmaceuticals Inc is operating .

  • Measures how much profit Adial Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Adial Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y--477.4%+477.4%
10Y--625.6%+625.6%
1.2.2. Operating Ratio

Measures how efficient Adial Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Adial Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY-3.783-3.783
5Y-5.679-5.679
10Y-7.894-7.894

1.3. Liquidity of Adial Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Adial Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.90 means the company has $4.90 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Adial Pharmaceuticals Inc:

  • The MRQ is 4.898. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.827. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.898TTM3.827+1.071
TTM3.827YOY3.687+0.140
TTM3.8275Y6.722-2.895
5Y6.72210Y6.573+0.148
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8983.914+0.984
TTM3.8274.220-0.393
YOY3.6875.388-1.701
5Y6.7226.045+0.677
10Y6.5736.406+0.167
1.3.2. Quick Ratio

Measures if Adial Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 4.33 means the company can pay off $4.33 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Adial Pharmaceuticals Inc:

  • The MRQ is 4.329. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.275. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.329TTM3.275+1.054
TTM3.275YOY3.190+0.085
TTM3.2755Y6.019-2.744
5Y6.01910Y5.800+0.219
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3293.572+0.757
TTM3.2753.998-0.723
YOY3.1905.390-2.200
5Y6.0195.969+0.050
10Y5.8006.287-0.487

1.4. Solvency of Adial Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Adial Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Adial Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.14 means that Adial Pharmaceuticals Inc assets are financed with 13.8% credit (debt) and the remaining percentage (100% - 13.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Adial Pharmaceuticals Inc:

  • The MRQ is 0.138. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.148. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.138TTM0.148-0.010
TTM0.148YOY0.408-0.260
TTM0.1485Y0.245-0.097
5Y0.24510Y2.470-2.225
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1380.336-0.198
TTM0.1480.334-0.186
YOY0.4080.269+0.139
5Y0.2450.366-0.121
10Y2.4700.390+2.080
1.4.2. Debt to Equity Ratio

Measures if Adial Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 16.0% means that company has $0.16 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Adial Pharmaceuticals Inc:

  • The MRQ is 0.160. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.175. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.160TTM0.175-0.015
TTM0.175YOY0.816-0.641
TTM0.1755Y0.410-0.235
5Y0.41010Y0.327+0.082
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1600.382-0.222
TTM0.1750.396-0.221
YOY0.8160.335+0.481
5Y0.4100.434-0.024
10Y0.3270.465-0.138

2. Market Valuation of Adial Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Adial Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -0.29 means the investor is paying $-0.29 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Adial Pharmaceuticals Inc:

  • The EOD is -0.418. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.288. Based on the earnings, the company is expensive. -2
  • The TTM is -0.348. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.418MRQ-0.288-0.130
MRQ-0.288TTM-0.348+0.060
TTM-0.348YOY0.006-0.354
TTM-0.3485Y-0.241-0.107
5Y-0.24110Y-0.223-0.018
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.418-2.259+1.841
MRQ-0.288-2.569+2.281
TTM-0.348-2.664+2.316
YOY0.006-4.120+4.126
5Y-0.241-6.258+6.017
10Y-0.223-6.171+5.948
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Adial Pharmaceuticals Inc:

  • The EOD is -0.656. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.452. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.443. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.656MRQ-0.452-0.204
MRQ-0.452TTM-0.443-0.009
TTM-0.443YOY-0.079-0.364
TTM-0.4435Y-0.331-0.112
5Y-0.33110Y-0.329-0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.656-2.924+2.268
MRQ-0.452-3.246+2.794
TTM-0.443-3.488+3.045
YOY-0.079-5.620+5.541
5Y-0.331-8.315+7.984
10Y-0.329-8.826+8.497
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Adial Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.54 means the investor is paying $0.54 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Adial Pharmaceuticals Inc:

  • The EOD is 0.786. Based on the equity, the company is cheap. +2
  • The MRQ is 0.542. Based on the equity, the company is cheap. +2
  • The TTM is 0.874. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.786MRQ0.542+0.244
MRQ0.542TTM0.874-0.333
TTM0.874YOY0.225+0.649
TTM0.8745Y0.564+0.310
5Y0.56410Y0.453+0.111
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.7861.851-1.065
MRQ0.5422.090-1.548
TTM0.8742.095-1.221
YOY0.2252.844-2.619
5Y0.5643.466-2.902
10Y0.4533.815-3.362
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Adial Pharmaceuticals Inc.

3.1. Institutions holding Adial Pharmaceuticals Inc

Institutions are holding 15.911% of the shares of Adial Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Armistice Capital, LLC9.55860.0041590001590000
2023-12-31Manchester Capital Management LLC2.89150.0124809700
2023-12-31Renaissance Technologies Corp1.39470.000123200232000
2023-12-31Susquehanna International Group, LLP0.8891014789147890
2023-12-31BlackRock Inc0.45920763900
2023-12-31Tower Research Capital LLC0.25450.0001423442340
2023-12-31UBS Group AG0.2177036223076563.37
2023-12-31JPMorgan Chase & Co0.15030250025000
2023-12-31Advisor Group Holdings, Inc.0.0373062050.813
2023-12-31Focused Wealth Strategies, INC.0.0330.00025495490
2023-12-31Benjamin F. Edwards & Company, Llc0.002404000
2023-12-31Royal Bank of Canada0.002303800
2023-12-31Morgan Stanley - Brokerage Accounts0.000509-12-57.1429
2023-12-31Wells Fargo & Co0.00050800
2023-12-31Qube Research & Technologies0.00050800
2023-09-30Creative Planning Inc000-400-100
2023-09-30BB&T Corp.000-1354-100
2023-09-30Virtu Financial LLC000-1059-100
2023-09-30Envestnet Asset Management Inc000-524-100
Total 15.89210.0164264353+204004+77.2%

3.2. Funds holding Adial Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.56260935900
2024-02-29Fidelity Extended Market Index0.19710327900
2024-02-29Fidelity Series Total Market Index0.0575095700
2024-02-29Fidelity Nasdaq Composite Index0.0397066100
2023-12-31Northern Trust Extended Eq Market Idx0.036059800
2023-12-31NT Ext Equity Mkt Idx Fd - L0.036059800
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0313052000
2024-02-29Fidelity Total Market Index0.0307051000
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0251041810.2398
2023-12-31SSgA U.S. Extended Market Index Class I0.0185030800
2024-03-31State St US Extended Mkt Indx NL Cl C0.0185030800
2024-02-29Spartan Total Market Index Pool E0.0158026200
2023-12-31SSgA U.S. Total Market Index Strategy0.0054089-2-2.1978
2024-02-29State St US Ttl Mkt Indx SL Cl I0.005308800
2023-12-31NT US Market Cap Idx Fd - L0.003105200
2023-12-31Northern Trust Wilshire 50000.0031052-1264-96.0486
2023-09-30BlackRock Extended Mkt Composite0.001903100
2024-03-31BlackRock Extended Equity Market K0.001602700
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00101700
2024-03-31Extended Equity Market Fund M0.00020300
Total 1.0904018137-1265-7.0%

3.3. Insider Transactions

Insiders are holding 9.802% of the shares of Adial Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-29Kevin SchuylerBUY7002.74

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Adial Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.0490.530+98%-1.393+233%-0.242+123%0.079+1224%
Book Value Per Share--2.4551.952+26%2.718-10%3.513-30%2.473-1%
Current Ratio--4.8983.827+28%3.687+33%6.722-27%6.573-25%
Debt To Asset Ratio--0.1380.148-7%0.408-66%0.245-44%2.470-94%
Debt To Equity Ratio--0.1600.175-9%0.816-80%0.410-61%0.327-51%
Dividend Per Share----0%-0%-0%-0%
Eps---1.154-0.444-62%-0.719-38%-1.460+26%-1.224+6%
Free Cash Flow Per Share---0.735-0.903+23%-1.651+125%-2045.475+278209%-1253.781+170491%
Free Cash Flow To Equity Per Share--1.299-0.197+115%1.183+10%175371.760-100%107486.132-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---121820.132--------
Intrinsic Value_10Y_min---106260.054--------
Intrinsic Value_1Y_max---13870.168--------
Intrinsic Value_1Y_min---13624.848--------
Intrinsic Value_3Y_max---40406.901--------
Intrinsic Value_3Y_min---38601.349--------
Intrinsic Value_5Y_max---65416.009--------
Intrinsic Value_5Y_min---60826.517--------
Market Cap3210400.600+31%2212349.9302394271.744-8%937753.025+136%2868357.744-23%2363027.666-6%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.786+31%0.5420.874-38%0.225+140%0.564-4%0.453+20%
Pe Ratio-0.418-45%-0.288-0.348+21%0.006-4831%-0.241-16%-0.223-22%
Price Per Share1.930+31%1.3301.439-8%0.564+136%1.724-23%1.421-6%
Price To Free Cash Flow Ratio-0.656-45%-0.452-0.443-2%-0.079-83%-0.331-27%-0.329-27%
Price To Total Gains Ratio1.841+31%1.268-1.092+186%-0.381+130%-0.804+163%-1.419+212%
Quick Ratio--4.3293.275+32%3.190+36%6.019-28%5.800-25%
Return On Assets---0.405-0.200-51%-0.497+22%-0.387-5%-1.501+270%
Return On Equity---0.470-0.245-48%-0.982+109%-0.611+30%-0.663+41%
Total Gains Per Share--1.0490.530+98%-1.393+233%-0.242+123%0.079+1224%
Usd Book Value--4083529.0003246659.333+26%4521691.750-10%5843978.316-30%4113801.161-1%
Usd Book Value Change Per Share--1.0490.530+98%-1.393+233%-0.242+123%0.079+1224%
Usd Book Value Per Share--2.4551.952+26%2.718-10%3.513-30%2.473-1%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.154-0.444-62%-0.719-38%-1.460+26%-1.224+6%
Usd Free Cash Flow---1222555.000-1502665.333+23%-2747011.250+125%-3402483836.263+278209%-2085565170.032+170491%
Usd Free Cash Flow Per Share---0.735-0.903+23%-1.651+125%-2045.475+278209%-1253.781+170491%
Usd Free Cash Flow To Equity Per Share--1.299-0.197+115%1.183+10%175371.760-100%107486.132-100%
Usd Market Cap3210400.600+31%2212349.9302394271.744-8%937753.025+136%2868357.744-23%2363027.666-6%
Usd Price Per Share1.930+31%1.3301.439-8%0.564+136%1.724-23%1.421-6%
Usd Profit---1920333.000-739168.333-62%-3163312.000+65%-2834345.842+48%-2268482.645+18%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--1.0490.530+98%-1.393+233%-0.242+123%0.079+1224%
 EOD+6 -2MRQTTM+20 -9YOY+22 -75Y+18 -1110Y+18 -11

4.2. Fundamental Score

Let's check the fundamental score of Adial Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.418
Price to Book Ratio (EOD)Between0-10.786
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.329
Current Ratio (MRQ)Greater than14.898
Debt to Asset Ratio (MRQ)Less than10.138
Debt to Equity Ratio (MRQ)Less than10.160
Return on Equity (MRQ)Greater than0.15-0.470
Return on Assets (MRQ)Greater than0.05-0.405
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Adial Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.523
Ma 20Greater thanMa 501.720
Ma 50Greater thanMa 1001.647
Ma 100Greater thanMa 2001.641
OpenGreater thanClose2.040
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. All numbers in thousands.

Summary
Total Assets4,737
Total Liabilities654
Total Stockholder Equity4,084
 As reported
Total Liabilities 654
Total Stockholder Equity+ 4,084
Total Assets = 4,737

Assets

Total Assets4,737
Total Current Assets3,199
Long-term Assets1,538
Total Current Assets
Cash And Cash Equivalents 2,827
Other Current Assets 372
Total Current Assets  (as reported)3,199
Total Current Assets  (calculated)3,199
+/-0
Long-term Assets
Long-term Assets Other 4
Long-term Assets  (as reported)1,538
Long-term Assets  (calculated)4
+/- 1,534

Liabilities & Shareholders' Equity

Total Current Liabilities653
Long-term Liabilities0
Total Stockholder Equity4,084
Total Current Liabilities
Accounts payable 127
Other Current Liabilities 526
Total Current Liabilities  (as reported)653
Total Current Liabilities  (calculated)653
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/- 0
Total Stockholder Equity
Common Stock2
Retained Earnings -68,798
Other Stockholders Equity 72,880
Total Stockholder Equity (as reported)4,084
Total Stockholder Equity (calculated)4,084
+/-0
Other
Cash and Short Term Investments 2,827
Common Stock Shares Outstanding 1,663
Liabilities and Stockholders Equity 4,737
Net Debt -2,827
Net Working Capital 2,546



Balance Sheet

All numbers in thousands.

 Trend2024-03-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-31
> Total Assets 
216
0
0
152
0
196
79
35
80
187
5,252
4,699
12,060
10,687
9,507
7,680
5,941
9,475
8,178
5,491
8,625
8,063
10,446
7,475
13,964
10,923
7,742
5,733
3,902
3,779
2,867
4,737
4,7372,8673,7793,9025,7337,74210,92313,9647,47510,4468,0638,6255,4918,1789,4755,9417,6809,50710,68712,0604,6995,252187803579196015200216
   > Total Current Assets 
206
0
0
141
0
188
71
27
73
180
5,245
4,693
12,053
10,681
9,501
7,673
5,935
9,469
8,172
5,136
6,172
5,590
7,986
6,462
12,965
9,940
6,773
4,780
2,965
2,047
1,135
3,199
3,1991,1352,0472,9654,7806,7739,94012,9656,4627,9865,5906,1725,1368,1729,4695,9357,6739,50110,68112,0534,6935,245180732771188014100206
       Cash And Cash Equivalents 
163
0
0
88
0
137
40
18
54
150
4,817
3,869
11,394
10,254
8,530
6,777
4,952
8,624
7,365
4,401
5,638
5,210
7,180
6,062
12,689
9,157
5,753
4,002
2,313
1,218
316
2,827
2,8273161,2182,3134,0025,7539,15712,6896,0627,1805,2105,6384,4017,3658,6244,9526,7778,53010,25411,3943,8694,81715054184013708800163
       Net Receivables 
0
0
0
35
0
0
0
0
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
737
350
0
03507370000000000000000000010000035000
       Other Current Assets 
43
0
0
18
0
51
31
9
9
30
429
318
659
155
511
359
240
177
593
502
298
147
570
390
266
194
504
349
223
91
470
372
37247091223349504194266390570147298502593177240359511155659318429309931510180043
   > Long-term Assets 
0
0
0
10
0
8
7
7
7
7
7
7
7
6
6
6
6
6
6
356
2,453
2,473
2,461
1,013
999
984
968
953
937
1,732
1,732
1,538
1,5381,7321,7329379539689849991,0132,4612,4732,45335666666677777778010000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
313
333
321
304
290
275
260
244
229
0
0
0
00022924426027529030432133331300000000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
131
131
131
249
249
249
249
249
249
0
0
0
00024924924924924924913113113100000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,728
1,728
0
01,7281,72800000000000000000000000000000
       Intangible Assets 
8
0
0
8
0
8
7
7
7
7
7
7
7
6
6
6
6
6
6
6
460
460
460
460
460
460
460
459
459
4
4
0
04445945946046046046046046046066666667777777808008
       Long-term Assets Other 
0
0
0
2
0
0
0
0
7
7
7
7
7
6
6
6
6
6
6
350
1,548
1,548
1,548
701
689
676
662
455
635
1,728
0
4
401,7286354556626766897011,5481,5481,5483506666667777700002000
> Total Liabilities 
53
0
0
255
0
661
743
1,032
1,387
1,481
323
258
329
627
777
539
390
682
1,093
1,505
3,008
3,234
3,246
3,967
3,256
2,962
2,333
2,456
2,462
462
528
654
6545284622,4622,4562,3332,9623,2563,9673,2463,2343,0081,5051,0936823905397776273292583231,4811,3871,03274366102550053
   > Total Current Liabilities 
53
0
0
255
0
661
743
1,032
1,387
1,481
323
258
329
627
777
539
390
682
1,093
1,505
2,042
2,213
1,958
2,722
2,171
1,867
1,327
1,791
1,798
462
528
653
6535284621,7981,7911,3271,8672,1712,7221,9582,2132,0421,5051,0936823905397776273292583231,4811,3871,03274366102550053
       Short-term Debt 
0
0
0
234
0
497
515
689
969
998
139
0
0
0
0
0
0
0
0
0
73
46
48
50
51
53
55
57
59
0
0
0
0005957555351504846730000000001399989696895154970234000
       Short Long Term Debt 
0
0
0
234
0
497
515
689
969
998
0
0
0
0
0
0
0
0
0
0
29
0
0
0
0
0
0
0
0
0
0
0
000000000002900000000009989696895154970234000
       Accounts payable 
37
0
0
20
0
164
227
342
417
482
184
258
329
627
475
190
196
442
247
649
637
477
185
286
415
618
278
394
530
112
82
127
127821125303942786184152861854776376492474421961904756273292581844824173422271640200037
       Other Current Liabilities 
16
0
0
1
0
165
228
1
1
1
184
0
0
627
302
349
193
240
846
857
1,331
1,690
1,725
10
1,705
1,196
994
1,340
1,209
350
446
526
5264463501,2091,3409941,1961,705101,7251,6901,33185784624019334930262700184111228165010016
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
966
1,021
1,288
1,245
1,085
1,095
1,006
665
664
0
0
0
0006646651,0061,0951,0851,2451,2881,02196600000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
726
793
0
0
0
0
0
0
0
0
0
0
000000000079372600000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
726
793
1,068
1,037
891
915
840
0
0
0
0
0
000008409158911,0371,06879372600000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,548
1,548
1,548
0
0
0
0
0
0
0
0
0
0000000001,5481,5481,54800000000000000000000
> Total Stockholder Equity
163
0
0
-103
0
-466
-664
-998
-1,307
-1,294
4,929
4,441
11,731
10,061
8,730
7,141
5,551
8,793
7,085
3,986
5,618
4,829
7,200
3,508
10,707
7,961
5,409
3,276
1,440
3,317
2,339
4,084
4,0842,3393,3171,4403,2765,4097,96110,7073,5087,2004,8295,6183,9867,0858,7935,5517,1418,73010,06111,7314,4414,929-1,294-1,307-998-664-4660-10300163
   Common Stock
9,681
0
0
9,835
0
9,916
10,009
3
3
4
7
7
10
10
10
10
11
13
14
14
17
18
20
21
24
26
27
27
29
1
1
2
21129272726242120181714141311101010107743310,0099,91609,835009,681
   Retained Earnings -68,798-66,878-65,493-66,580-63,675-60,808-57,698-53,851-50,943-45,112-40,794-36,354-31,520-28,051-24,715-22,904-20,627-18,568-16,852-14,718-12,035-10,766-2,575-783-404-10,674-10,3810-9,93800-9,518
   Capital Surplus 
0
0
0
0
0
0
0
0
0
1,278
15,689
16,470
26,439
26,903
27,288
27,757
28,444
33,494
35,121
35,491
41,954
45,605
0
0
0
0
0
0
0
0
0
0
000000000045,60541,95435,49135,12133,49428,44427,75727,28826,90326,43916,47015,6891,278000000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
-597
-528
1,278
15,689
16,470
26,439
26,903
27,288
27,757
28,444
33,494
35,121
35,491
41,954
45,605
52,292
54,430
64,535
65,634
66,190
66,924
67,992
68,809
69,216
72,880
72,88069,21668,80967,99266,92466,19065,63464,53554,43052,29245,60541,95435,49135,12133,49428,44427,75727,28826,90326,43916,47015,6891,278-528-5970000000



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1
Gross Profit-1-1
 
Operating Income (+$)
Gross Profit-1
Operating Expense-6,887
Operating Income-6,888-6,888
 
Operating Expense (+$)
Research Development1,267
Selling General Administrative5,621
Selling And Marketing Expenses1
Operating Expense6,8876,889
 
Net Interest Income (+$)
Interest Income106
Interest Expense-0
Other Finance Cost-0
Net Interest Income106
 
Pretax Income (+$)
Operating Income-6,888
Net Interest Income106
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,002-6,774
EBIT - interestExpense = -6,888
-9,627
-7,748
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-6,888-7,002
Earnings Before Interest and Taxes (EBITDA)-6,887
 
After tax Income (+$)
Income Before Tax-7,002
Tax Provision--1
Net Income From Continuing Ops-9,582-7,001
Net Income-7,748
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses6,888
Total Other Income/Expenses Net-114-106
 

Technical Analysis of Adial Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Adial Pharmaceuticals Inc. The general trend of Adial Pharmaceuticals Inc is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Adial Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Adial Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.1699 < 4.3 < 4.46.

The bearish price targets are: 1.05 > 0.765.

Tweet this
Adial Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Adial Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Adial Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Adial Pharmaceuticals Inc. The current macd is 0.17918199.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Adial Pharmaceuticals Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Adial Pharmaceuticals Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Adial Pharmaceuticals Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Adial Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartAdial Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Adial Pharmaceuticals Inc. The current adx is 34.49.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Adial Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Adial Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Adial Pharmaceuticals Inc. The current sar is 1.64804278.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Adial Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Adial Pharmaceuticals Inc. The current rsi is 51.52. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Adial Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartAdial Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Adial Pharmaceuticals Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Adial Pharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Adial Pharmaceuticals Inc Daily Stochastic Oscillator ChartAdial Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Adial Pharmaceuticals Inc. The current cci is 33.90.

Adial Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartAdial Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Adial Pharmaceuticals Inc. The current cmo is -0.58004247.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Adial Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartAdial Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Adial Pharmaceuticals Inc. The current willr is -57.07317073.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Adial Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Adial Pharmaceuticals Inc Daily Williams %R ChartAdial Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Adial Pharmaceuticals Inc.

Adial Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Adial Pharmaceuticals Inc. The current atr is 0.42848296.

Adial Pharmaceuticals Inc Daily Average True Range (ATR) ChartAdial Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Adial Pharmaceuticals Inc. The current obv is 354,623,011.

Adial Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartAdial Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Adial Pharmaceuticals Inc. The current mfi is 96.45.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Adial Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartAdial Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Adial Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Adial Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Adial Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.523
Ma 20Greater thanMa 501.720
Ma 50Greater thanMa 1001.647
Ma 100Greater thanMa 2001.641
OpenGreater thanClose2.040
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Adial Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Adial Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Adial Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Adial Pharmaceuticals Inc

I send you an email if I find something interesting about Adial Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Adial Pharmaceuticals Inc.

Receive notifications about Adial Pharmaceuticals Inc in your mailbox!